What is NovelStem International Financial Strength?
NovelStem International has the Financial Strength Rank of 0.
GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors:
1. The debt burden that the company has as measured by its
Interest Coverage (current year). The higher, the better.
2. Debt to revenue ratio. The lower, the better.
3.
Altman Z-Score.
NovelStem International did not have earnings to cover the interest expense.
NovelStem International's debt to revenue ratio for the quarter that ended in Mar. 2024 was 326.00.
As of today, NovelStem International's Altman Z-Score is -177.54.
Competitive Comparison of NovelStem International's Financial Strength
For the Diagnostics & Research subindustry, NovelStem International's Financial Strength, along with its competitors' market caps and Financial Strength data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NovelStem International's Financial Strength Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, NovelStem International's Financial Strength distribution charts can be found below:
* The bar in red indicates where NovelStem International's Financial Strength falls into.
NovelStem International Financial Strength Calculation
GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
NovelStem International's Interest Expense for the
months ended in Mar. 2024 was $-0.10 Mil. Its Operating Income for the
months ended in Mar. 2024 was $-0.18 Mil. And its Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $0.81 Mil.
NovelStem International's Interest Coverage for the quarter that ended in Mar. 2024 is
| NovelStem International did not have earnings to cover the interest expense. |
The higher the ratio, the stronger the company's financial strength is.
2. Debt to revenue ratio. The lower, the better.
NovelStem International's Debt to Revenue Ratio for the quarter that ended in Mar. 2024 is
3. Altman Z-Score.
Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
The zones of discrimination were as such:
When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.
NovelStem International has a Z-score of -177.54, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.
Warning Sign:
Altman Z-score of -177.54 is in distress zone. This implies bankruptcy possibility in the next two years.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NovelStem International (NovelStem International) Business Description
Traded in Other Exchanges
N/A
Address
2255 Glades Road, Suite 221A, Boca Raton, FL, USA, 33431
NovelStem International Corp owns novel stem-cell-based diagnostic technology for predicting patients' resistance to cancer therapies. The technology is also being used for genetic research related to other medical therapies.
Executives
| Baker Street Capital Management, Llc |
10 percent owner |
1875 CENTURY PARK EAST, SUITE 700, LOS ANGELES CA 90067 |
| Vadim Perelman |
10 percent owner |
1875 CENTURY PARK EAST, SUITE 700, LOS ANGELES CA 90067 |
| Baker Street Capital L.p. |
10 percent owner |
1875 CENTURY PARK EAST, SUITE 700, LOS ANGELES CA 90067 |
| Stephen Gans |
director, 10 percent owner |
14850 NW 44TH COURT, OPA LOCKA FL 33054 |
| Shannon River Partners Lp |
10 percent owner |
850 THIRD AVENUE, 13TH FLOOR, NEW YORK NY 10022 |
| Shannon River Fund Management Co Llc |
10 percent owner |
850 THIRD AVENUE, 13TH FLOOR, NEW YORK NY 10022 |
| Shannon River Partners Ii, Lp |
10 percent owner |
850 THIRD AVENUE, 13TH FLOOR, NEW YORK NY 10022 |
| Doonbeg Fund Lp |
10 percent owner |
850 THIRD AVE, 13TH FLOOR, New York ny 10022 |
| Spencer M. Waxman |
director |
C/O SHANNON RIVER PARTNERS, 800 THIRD AVENUE 30TH FLOOR, NEW YORK NY 10022 |
| Stanley Morgan |
10 percent owner |
1585 BROADWAY, NEW YORK NY 10036 |
| Robert D. Epstein |
director |
2255 GLADES ROAD, BOCA RATON FL 33431 |
| Coghill Capital Management Llc |
10 percent owner |
233 SOUTH WACKER DRIVE, SUITE 8439, CHICAGO IL 60606 |
| Ccm Master Fund Ltd |
10 percent owner |
C/O MORGAN STANLEY FUND SERVICES (CAYMAN, LTD CENTURY YARD CRICKET SQ HUTCHINGS DR, PO BOX 2681 GEORGE TOWN E9 00000 |
| Clint D Coghill |
10 percent owner |
|
| Scott Gomez |
officer: Chief Accounting Officer |
|
NovelStem International (NovelStem International) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NSTM has been successfully added to your